Interestingly, neutrophils expressing HLA-DR and CD74 have been identified as alternative antigen-presenting cells (APCs) in various cancer types.234 A previous study also reported that coupling anti-FcγRIIIB with antigens converted neutrophils into APCs,235 revealing novel therapeutic avenues in cancer treatment. The gene discussed is CD74; the disease is cancer.